Xcout Intel
Innova Vascular, Inc.
Innova Vascular, Inc. is a medical device company based in Irvine, California, engaged in the development of innovative minimally invasive vascular technologies such as the Laguna Thrombectomy System.
Subscribe to see Innova Vascular, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Innova Vascular, Inc. at a glance
Innova Vascular, Inc. is a medical devices company headquartered in United States. It has raised at least $19.7M across the 3 funding rounds on record. Its most recent funding round, Series A, raised $10M in May 2025. Xcout tracks 10 named people at Innova Vascular, Inc., including Sanjay Shrivastava (Chief Executive Officer).
Innova Vascular, Inc. leadership
- Sanjay ShrivastavaChief Executive Officer
- Dr. Sanjay ShrivastavaChief Executive Officer
- Paul MullenVP, Sales
- Sanjay ShrivastavaExecutive Officer
- Michael J. Hennessy, Jr.Chief Executive Officer and President for MJH Life Sciences™
- Dr. Owen O NiellOrthopedic Surgeon & President Twin Cities Orthopedics
4 more named people on record for Innova Vascular, Inc., with roles, board committees and tenure — see the full roster →
Innova Vascular, Inc. funding rounds
At least $19.7M raised across the 3 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $10M | — | |
| SEC Form D filing | $5.7M | — | |
| SEC Form D filing | $4M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Innova Vascular, Inc. competitors
A few of Innova Vascular, Inc.'s closest competitors — see the full list of competitors and alternatives →
enVVeno Medical Corporation, based in Irvine, California, is a medical device firm founded in 1999 that is currently in its clinical development phase. The company's primary objective is to pioneer advanced bioprosthetic, tissue-engineered solutions intended to significantly elevate the existing standards of care for patients suffering from venous conditions. Their flagship product is the VenoValve, a specialized replacement venous valve developed for the management of chronic venous insufficiency. This device requires an open surgical procedure for implantation, which involves making a 5-to-6-inch incision in the patient's upper thigh to facilitate placement into the femoral vein. In addition to the VenoValve, enVVeno Medical is actively developing the enVVe system. This innovative system represents a non-surgical, transcatheter approach to venous valve replacement, comprising the enVVe valve itself, a dedicated delivery mechanism, and various supplementary accessories. The company previously operated under the name Hancock Jaffe Laboratories, Inc., before officially rebranding to enVVeno Medical Corporation in October 2021.
InVera Medical is a medical device company based in the medtech cluster of Galway, Ireland. The company focuses on developing next-generation, less invasive treatment solutions for patients suffering from chronic venous disease.
Venova Medical Inc. is a clinical-stage medical device company headquartered in Los Gatos, California. Founded in 2018, the firm focuses on addressing challenges associated with providing optimal vascular access for patients requiring hemodialysis. The privately held company develops specialized vascular technologies to improve patient care outcomes.
Integrated Vascular Systems Inc. is headquartered in Sunnyvale, California, and operates within the vascular medical device and systems market.
Laguna Tech USA, Inc. is a medical technology company that develops structural heart solutions, specifically focusing on transcatheter aortic valve systems. The company's flagship product, the ZETA Transcatheter Aortic Valve System, is an investigational device designed to treat both aortic regurgitation and aortic stenosis.
Cognition Med, LLC develops interventional neurovascular medical devices designed to treat stroke patients through minimally-invasive endovascular procedures. The company focuses on creating technologies to remove blood clots from blood vessels in the brain.
Get Innova Vascular, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Innova Vascular, Inc. in Xcout Intel
- 10 named people with titles, LinkedIn and board committees
- 3 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access